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ABSTRACT  
Objective: L-Asparaginase enzyme possesses a crucial role in the treatment of various hematologic malignancies. The current study focuses on 
homology modeling and interaction analysis of L-Asparaginase proteins belonging to Streptomyces albidoflavus (S. albidoflavus) with the essential 
ligand L-Asparagine and subsequent analysis with essential β-lactam antibiotic Cefotaxime.  
Methods: The process of understanding Asparaginase interactions primarily involved structure determination of WP_096097608, WP_095730301, 
which is achieved by GalaxyTBM, I-TASSER and SWISS-MODEL. Further, the S. albidoflavus Asparaginase proteins are subjected to GalaxySite and 
Autodock Vina of PyRx analysis.  
Results: The GalaxyTBM predicted structures of both the proteins are found promising on various validation studies. The two Asparaginase 
proteins exhibited high binding affinities of-6.8 and-6.5 kcal/mol with Cefotaxime and-5.1 and-4.9 kcal/mol towards Asparagine. The protein 
WP_096097608 residues forming hydrogen bonds with L-Asparagine are also analysed to involve in interaction with Cefotaxime on individual 
docking analysis.  
Conclusion: The current findings details the two S. albidoflavus Asparaginase proteins affinity towards L-Asparagine, hence can be assessed further 
for immunogenicity studies. In addition to the above findings, an attempt is made to find the L-Asparaginase binding possibilities with non-metals 
that identified an essential β-lactam antibiotic Cefotaxime to be an effective inhibitor. This study helps in understanding the interactions of L-
Asparaginase with Cefotaxime, as intake of antibiotics between the phases of chemotherapy is observed to treat various infections and also as an 
antibiotic to microbes that utilize Asparaginase as a vital enzyme.  
Keywords: L-Asparaginase, Streptomyces, Homology modelling, GalaxyTBM, I-TASSER, L-Asparagine, Cefotaxime 
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INTRODUCTION 
The L-Asparaginase (Asp) enzyme currently administered for Acute 
Lymphoblastic Leukemia (ALL) is obtained from the Erwinia 
chrysanthemi and Escherichia coli [1]. The high efficacy of Asp in 
treating ALL is also observed in diverse groups such as in pubescent 
and in adults [2, 3] apart from children who are highly susceptible to 
ALL [4, 5]. 
Antibiotics are highly popular metabolites that are prioritized in 
treating multiple infections, in particular, display a pivotal role in 
inhibiting the proliferation of malignant cells and restraining 
metastasis [7]. Despite the benefits, they are perceived to be 
detrimental to beneficial microbes [8]. Hence the studies involving 
essential Asparaginase and antibiotic Cefotaxime can be found useful 
in understanding the interactions as usage of antibiotics by the 
cancer patients is observed to treat infections. 
Although Asparaginase as a medication possesses a vital 
role in hematologic malignancy treatment, it is reported that it may 
aggravate allergic and toxic reactions in some patients [6] which is 
considered as the prime objective to identify new Asp enzyme 
sources. As the Asp protein interaction with Asparagine has high 
significance in the field of medicine in breaking down asparagine 
into two different compounds aspartic acid and ammonia, thereby 
initiating the death of the tumor cells.  
The various computational methodologies applied for the current 
analysis includes template-based assessments and ab initio 
modeling which are considered prominent to evaluate the protein 
3D structure. The computational approach provides a detailed 
assessment of the properties and interactions of the significant 
compound thus minimizes the errors and undesirable results during 
in vitro analysis [9]. The approach towards high accuracy of protein 
structures involves the execution of energy and structural 
refinements, retaining similarity to the native conformations [10, 
11]. A detailed overview of the refined structures and the active sites 
in quick time is crucial for the formulation of useful therapeutic 
metabolites [12]. It would be also significant to understand the 
interaction of Asp enzyme of two S. albidoflavus with Asparagine for 
quest about alternative enzyme formulations. The current study 
aims to find the Streptomyces albidoflavus (S. albidoflavus) Asp 
protein binding potentiality with its natural target inhibitor L-
Asparagine (Asparagine) and binding possibilities with non-metals. 
MATERIALS AND METHODS 
Sequence retrieval and determination of protein characteristics 
The Asp protein sequences with accession numbers WP_096097608, 
WP_095730301 belonging to S. albidoflavus are obtained in FASTA 
format from the National Center for Biotechnology Information 
database [13]. The protein sequences are searched for similar 
entries with the application of BLAST tool [14] in the UniProtKB 
database, a prioritized protein knowledgebase to maintain accurate 
protein information with access to entries from different protein data 
sources [15]. The sequence alignment of the query protein sequences 
and the resulted protein sequences are analyzed by ClustalW [16] and 
individual phylogenetic trees are built by the Neighbor-joining method 
[17] with the default criteria of 1000 bootstrap values [18] in the 
desktop version of the MEGA X application [19]. The proteins are 
assessed by the ExPASy ProtParam studies to evaluate the 
physicochemical features, similarities and differences in the 
characteristics of two Asp proteins [20]. 
Asp proteins structural elucidation and molecular annotation 
The Asp proteins are evaluated for the presence of helix, Pi helix, 
strands, turns, coils and beta bridges by the SOPMA programme 
[21]. In addition, brief insights into the secondary structure are also 
provided by the I-TASSER along with the confidence score [22]. 
Besides, the proteins are further subjected to analysis with NCBI-
CDD [23], Pfam database [24]. Structural evaluation of Asp proteins 
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is achieved by SWISS-MODEL [25], GalaxyTBM [26] and I-TASSER 
[22]. Refinement of the resulted models is performed by Galaxy 
Refine [27] followed by assessment with PROCHECK [28] ProSA web 
server and ERRAT analysis [29, 30].  
Molecular docking studies of Asp proteins  
The binding pockets, functional annotations of the proposed protein 
models are fetched by two docking methodologies namely 
GalaxySite [31] and AutoDock Vina 1.1.2 [32], an integrated 
methodology of PyRx 0.8 [33]. GalaxySite program is executed by 
embedding structure determination methods namely GalaxyTBM 
[26] template identification by HHsearch and protein-ligand docking 
approach by LigDockCSA [34, 35]. The docked results of Asp 
proteins are finally visualized in Discovery studio v21 [36]. 
RESULTS AND DISCUSSION 
The Asp protein sequences of S. albidoflavus featuring accession 
numbers WP_096097608, WP_095730301 are selected for the 
current study. The sequences are described as non-redundant as per 
the literature available [13].  
Phylogenetic analysis of Asp proteins 
The Asp protein sequences are analyzed for similar proteins by the 
application of BLAST tool [14] in the vast UniProtKB database [15] 
and the resulted sequences are aligned by the ClustalW [16] the 
phylogenetic relationship is derived by the Neighbor-joining method 
[17] of the MEGA X version [19]. The protein WP_096097608 
exhibited clade formation with Asparaginase proteins of the same 
species with accession number A0A2A2UM91 (99.7% sequence 
similarity) and with Streptomyces sp. FR-008 (A0A0S1UPU4) 
(99.2% sequence similarity) (fig 1A). Similarly, the protein with 
accession number A0A2A2UM91 of S. albidoflavus appeared 100% 
identical categorizing into the same clade with WP_095730301 (fig 
1B). In addition, many Asparaginase protein sequences belonging to 
unspecified species of the Streptomyces family appeared to be in 
clusters with the query proteins as represented in fig 1A and 1B. A 
protein of S. koyangensis A0A385DBJ8 is observed to be 95.9% and 
96.1% identical with the two Asp proteins WP_096097608 and 
WP_095730301 accordingly indicating a phylogenetic relationship. 
Thus the analysis enables interpretation of the protein 
characteristics depending on the level of sequence identity. Fig.1A 
and 1B details the phylogenetic tree of the Asp protein sequences 
that exhibited identity greater than 95% with different entries of 
UniProtKB [15]. 
Analysis of Asp protein sequence characteristics 
The physicochemical profiling of the proteins by the ExPASY 
ProtParam tool are detailed in table 1. The protein sequences 
WP_096097608 is found to possess 328 amino acids (AA) 
corresponding to 4808 atoms while WP_095730301 possessed 309 
AA with 4555 atoms. The molecular weight of the sequences 
WP_096097608, WP_095730301 are found to be 34171.28 Da, 
32318.17 Da respectively. The instability index findings categorized 
the proteins to be stable with an index value found within the 
acceptable range. The proteins Aliphatic index (AI) ranged 90.34, 
92.72 as described in table 1, the AI values observed between 40-77 
and values>100 are also reported by Manochitra and team, and also 
by Appaiah and colleagues [37, 38]. The GRAVY values of S. 
albidoflavus Asp proteins are determined to be 0.058 and 0.090, 
identifying the proteins as hydrophobic. Similar positive values of 
0.106, 0.237 are reported by Bagag and his team [39]. Methionine is 
identified as an N-terminal for the two proteins is considered 
significant in measuring the half-life of the protein [20]. The half-life 
assessments are sum up between 10 to 30 h as per the studies 
pertaining to E. coli, yeast and mammalian reticulocytes. 
 
 
Fig. 1: Phylogenetic tree of [A] WP_096097608, [B] WP_095730301 with protein sequences of UniProtKB constructed by Neighbor-joining 
method of MEGA X version 
Ramesh et al. 
Int J App Pharm, Vol 13, Issue 4, 2021, 160-167 
 
162 
Table 1: ProtParam assessment of the S. albidoflavus Asp protein sequences. AA count: Amino acid count; Mwt: Molecular weight; pI value: 
Theoretical pI; (-)r: negatively charged residues; (+)r: positively charged residues; Ec: Extinction coefficient; CC: Cys residues form 
cystines; CR: Cys residues are reduced; HL: Half-life; I Index: Instability index; A Index: Aliphatic Index 
Parameters Sequence details 
WP_096097608 WP_095730301 
AA count 328 309 
MWt (Da) 34171.28 32318.17 
pI value 6.11 5.75 
(-) residues 36 35 
(+) residues 33 30 
Formula C1496H2412N444O440S C16 1422H2287N415O417S
Ec value 
14 
CC 22835 22710 
CR 22460 22460 
HL (hr) in vitro 30 30 
invivo 20,10 20,10 
II value 35.52 33.68 
AI value 90.34 92.72 
Gravy 0.058 0.09 
 
Asp proteins structural elucidation and molecular annotation 
The secondary structure evaluation of Asp proteins by SOPMA 
exhibited varied results with high dominance of random coils (Cc) in 
WP_096097608 with 38.72%, followed by 34.76% of alpha-helices 
(Hh), 15.85% of the extended strand (Ee) and 10.67% of beta 
turns(Tt). The protein WP_095730301 is determined to be rich in 
alpha-helical formation with 40.45% of Hh, 33.66% of Cc, 14.89% of 
Ee, 11% of Tt. The secondary structure possessing alpha-helices 
(three long and four short lengths), four beta-strands and a set of 
coils and strands laid between the helices is described by PSIPRED 
during the I-TASSER WP_096097608 structural evaluation process 
[40]. Similarly, WP_095730301 is described to be made of four beta-
strands and six (four long and two short lengths) alpha-helices 
which are interlinked with each other by a short length coil. The 
functional annotations of WP_096097608, WP_095730301 on 
prediction with NCBI-CDD and Pfam servers identified the proteins 
to be members of PF06089, L-Asparaginase II protein family with 
alignments between 22~325 AA, 3~306 AA. The NCBI-CDD results 
are also in agreement with Pfam analysis as the proteins belong to 
pfam06089-L-Asparaginase II superfamily. The residue range 24-
326, 5-307 has an E-value 1.18e-137 and 7.13e-138 respectively. 
The application of I-TASSER and GalaxyTBM resulted in five 3D 
protein models by each tool while the SWISS-MODEL resulted in 
numerous predictions displaying identity between the target and the 
templates. The target-template identity analysed by SWISS-MODEL 
is found to be low for both the proteins of interest. The predictions 
of GalaxyTBM and I-TASSER are considered for further structure 
validation and active site prediction methods. 
 
 
Fig. 2: GalaxyTBM predicted structures of [A] WP_096097608 
[B] WP_095730301 
 
GalaxyTBM incorporates multiple templates for structure 
determination, supported with ab initio modeling of loops to 
enhance the quality of the predicted models [26]. The GalaxyTBM 
prediction of WP_096097608 (fig. 2A) is coupled with refinement 
between the residues 109-117 while unreliable region ranging 
between 90-98, 120-128, 167-181 are refined for WP_095730301 
(fig. 2B). The templates considered for the structural development of 
the target are found common inferring similarity between the 
predicted structures of two proteins. The templates 5W2J_B, 
4O7D_A, 1MKI_B, 3IHB_A are evaluated for WP_096097608, 4O7D_A, 
1MKI_B, 5W2J_B, 4BQM_B, 3IHB_A for WP_095730301. 
The I-TASSER predictions of S. albidoflavus Asp protein sequences 
resulted in protein models scored individually between-5 to 2, 
termed as Confident score (C-score) [22]. The first predicted model 
of WP_096097608 is observed to have a TM score of 0.36±0.12 and 
RMSD 14.0±3.9 Å, C-score 3.13. The models between 2 to 5 
possessed a C-score of-3.95,-4.04,-4.16,-4.27. The predicted protein 
models of WP_095730301 exhibited a C-score of-2.83,-4.01,-3.61,-5 
and-3.43. The first model with a C-score of-2.83 is estimated to have 
a TM-score of 0.39±0.13, RMSD 13.0±4.2 Å. The PDB hits 1kykA, 
1ci9A, 3h2gA, 6vm5A, 1k474, 1xkz, 4mnr are the top aligned 
templates with normalized Z-score values greater than 1, considered 
as best alignment for WP_096097608. The TM-score and C-score of 
every protein model are considered crucial to understanding the 
protein characteristics. The TM-scores of the PDB entries with close 
structural identity exhibited a TM-score between 0.669-0.688, the 
highest TM-score of 0.688 is exhibited between the target protein 
and 3dwkC. The top-aligned PDB structures structurally similar PDB 
hits related to WP_095730301 are found identical to 
WP_096097608 protein structure prediction. However, the TM-
score of the structurally close proteins to WP_095730301 displayed 
much higher values ranging between 0.655-0.701, 2wafA being the 
most structurally similar protein.  
The structural refinement is achieved by GalaxyRefine followed by 
assessment by PROCHECK for the finest models predicted by 
GalaxyTBM and I-TASSER are described in table 2. The prominent 
model of WP_096097608 predicted by GalaxyTBM with 87.1 % (230 
AA), 9.8 % (26 AA), 2.3% (6 AA) of residues in the Ramachandran 
plot [41] is detailed in fig. 3A while WP_095730301 displayed 89.3 
% (225 AA), 8.3 % (21 AA), 0.8% (2 AA) of residues (fig. 3B) in the 
favoured, additionally and generously allowed regions sequentially, 
representing an acceptable quality proteins. The finest predicted 
model of I-TASSER exhibited a quality enhanced structure after 
refinement with 79.2%, 16.3%, 0.8% of AA residues referring to 
WP_096097608, 84.9%,11.1%,1.2% by WP_095730301 in the 
favoured, additionally and generously allowed segment. The 
proteins had persistent AA in the disallowed region with 3.8% (10 
AA) and 2.8% (7 AA) referring to the proteins sequentially. The 
impact of the AA on the stability and stereochemistry of the protein 
from the disallowed region is comparatively less in the GalaxyTBM 
protein models with 0.8% (2 AA), 1.6% (4 AA) than in the I-TASSER 
predicted models. 
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Table 2: Validation of Asp protein models determined by I-TASSER and GalaxyTBM, Asp protein 1: WP_096097608; Asp protein 2: 
WP_095730301 
Validation tool Regions Asp protein 1 Asp protein 2 
GalaxyTBM  I-TASSER  GalaxyTBM  I-TASSER  
PROCHECK  Favoured  87.1 79.2 89.3 84.9 
additionally allowed  9.8 16.3 8.3 11.1 
generously allowed 2.3 0.8 0.8 1.2 
Disallowed 0.8 3.8 1.6 2.8 
ProSA web  Z-score -5.31 -7.64 -5.3 -6.26 
ERRAT   86.039 79.365 89.161 80.208 
 
 




Fig. 4: Validation of S. albidoflavus Asp proteins determined by GalaxyTBM. Panel A, B details the ProSA analysis of WP_096097608 and 
WP_095730301 and panel C, D details the energy plot of the proteins respectively. The ERRAT quality analysis of WP_096097608 and 
WP_095730301 is represented by the panel’s E and F accordingly 
 
Fig. 4A and 4B depicts the “degree of nativeness” of proteins termed 
as Z-score resulted in in-5.31,-5.3 by ProSA web on analysis of the 
protein models determined from WP_096097608 and 
WP_095730301 sequences accordingly. The assessment of the 
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individual model quality by the residual energy plot detailed the 
models to have a majority of negative residual interaction with 
peaks generated below the baseline. Minimal exceptional positive 
peaks have emerged with a slight rise in positive energy concerning 
the model obtained from WP_096097608 (fig. 4C). Regarding the 
model obtained from WP_095730301, a substantial decrease in 
positive energy is observed with only a single peak formation (fig. 
4D). However, the total residual energies of both the models 
remained negative thus they are considered acceptable with scores 
in the approved range of other pre-determined proteins. Fig. 4E and 
4F illustrate favourable ERRAT scores of 86.039, 89.161 indicating 
high-quality proteins as an ERRAT score above 50 falls into an 
acceptable range [30]. 
The structure elucidated by GalaxyTBM is found promising, stable, 
with good stereochemistry among the protein models predicted by I-
TASSER and SWISS-MODEL as the greater than 90% of residues are 
resulted favuorable [28]. The resulted ProSA and ERRAT values are 
also found significant in comparison to the validation results of I-
TASSER predicted models. Therefore the GalaxyTBM predicted 
structure is chosen for further analysis on protein-ligand interaction 
with a therapeutic application.  
Analysis of Asp protein by Galaxysite tool 
As both the proteins belong to Asparaginase II, coincidentally all the 
templates for the ligand prediction are found to be structures of 
Penicillin-binding proteins as predicted by the GalaxySite tool 
however, the source organisms differed. The protein 
WP_096097608 is identified to bind to Ligand CEF (CEFOTAXIME) 
and CDS. Similarly, the Asp protein WP_095730301 displayed 
interactions with Ligands CDS and BMG. The interactions of the two 
proteins with the respective ligand are displayed through LIGPLOT 
[42] (fig. 5). 
  
 
Fig. 5: GalaxySite predicted interactions of Asp proteins visualized by Ligplot: [A] WP_096097608 with Cef (Cefotaxime) [B] 
WP_096097608 with Cds [C] WP_095730301 with Cds [4] WP_095730301 with Bmg 
 
CEF binds to WP_096097608 chain A at Gly 14, Ala 15, Gly 16, Pro 
17, Ser 62, Lys 65, Cys 145, Ser 146, Gly 186, Glu 187, Pro 188, Val 
189, Val 239, Lys 259, Met 260, Gly 261, Ala 262 and Gly 283. 
Hydrogen bonds formation is observed between O1 atom of 
Cefotaxime and Lysine 65, 259 residues of protein WP_096097608. 
Hydrophobic interactions are also observed between Cefotaxime 
and Ala 15, Ser 62, Cys 145, Ser 146, Pro 188, Val 189, Val 239, Met 
260, Gly 261, Ala 262, Gly 283 of WP_096097608.  
The ligand CDS interacts with 16 AA residues of WP_096097608, 
namely ser Ser 62S, Lys 65, Arg 83R, Cys 145, Ser 146, His 149, Gly 
186, Glu 187, Pro 188, Val 189, Val 239, Lys 259, Met 260, Ala 262, 
Gly 283 and Ala 284. CDS also bind with amino acid residues of 
WP_095730301 at ARG 42, GLU 108, GLN 111, TYR 112, SER 115, 
GLN 117, VAL 118, ARG 119, ARG 120, Pro 121, Ala 243, GLU 244. 
WP_095730301 is identified to bind with BMG at ARG 120,PRO 
121,TYR 219, VAL 220, ALA 221, GLY 222, MET241, GLY 242, Asp 
263, GLY 264, ALA 265, ARG 267. 
Among the above-identified non-metals compatible for binding with 
Asp proteins, Cef is known to be a β-lactam antibiotic with 
application in treating pneumonia [43] and also effective when 
provided to cancer patients to treat urinary tract infection, 
septicemia as per Rolston and team [44]. The antibiotic Cefotaxime 
in combination with Ciprofloxacin and Ofloxacin is reportedly found 
to be used in the treatment of neutropenia among cancer patients 
[45, 46]. The studies revealed that Cefotaxime is prescribed to all age 
groups including neonates [47]. 
Although GalaxySite analysis identified Cefotaxime binding to Asp 
protein WP_096097608, both the proteins binding residues and 
possibilities with Cefotaxime is studied in addition to Asparagine by 
Ramesh et al. 
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individual docking based on the interpretation that two Asp proteins 
belong to pfam06089 L-Asparaginase II superfamily. 
Molecular docking analysis of Asp proteins by Pyrx application 
The docking methodology of the Asp proteins is executed by Galaxysite 
and by Pyrx application. The ligands Asparagine (identifier 6267) and 
Cefotaxime (identifier 5742673) obtained from Pubchem [48] are 
subjected to blind docking by PyRx 0.8 application comprising an 
integrated AutoDock Vina version 1.1.2 tool. The Openbabel [49], an 
inbuilt version of Pyrx tool with a united force field and Chimera 1.14 
[50], a desktop application with default criteria of minimization are 
utilized to minimize and convert Asparagine and Cefotaxime into 
pdbqt format respectively. The predicted best structures of the 
proteins WP_096097608 and WP_095730301 are considered as 
macromolecules for analysis with the ligands sequentially. Nine 
predicted binding poses are identified for each individual Asp-
Asparagine, Asp-Cefotaxime combinations. The Asp protein 
WP_096097608 displayed a binding affinity of-5.1 kcal/mol,-6.8 
kcal/mol towards Asparagine and Cefotaxime respectively, followed 
by-4.9 kcal/mol,-6.5 kcal/mol for Asparagine and Cefotaxime 
accordingly by WP_095730301. The interpretation confirms both the 
ligands possess strong interactions towards WP_096097608.  
The Asp protein WP_096097608 exhibited three types of bonds with 
Asparagine (fig. 6A) comprising LYS 65, CYS 145, LYS 259, ALA 262 
with Hydrogen bond while SER 62 appeared with hydrogen and 
carbon-hydrogen bond. ARG 83, GLY 186, GLU 187, PRO 188, VAL 
189, MET 260, GLY 261, GLY 283 are found surrounding the ligand 
exhibiting van der Waal interactions.  
The Asp protein WP_096097608, Cefotaxime docked framework (fig. 
6B) is observed to have six types of bonds consisting of H bonds with 
GLY 14, SER 62, LYS 65, LYS 259. Gly 186 forming H bond with OH 
group of the ligand while ASP282 displayed an attractive charge and 
a π-anion. CYS 145, VAL 239 displayed with alkyl bonds in addition, 
the ligand is associated with thirteen residues featuring van der 
Waals interactions, namely ASP 13, ALA 15, PRO 17, ARG 83, SER 
146, GLU187, PRO 188, VAL 189, GLY 261, ALA 262, GLY 283, ALA 
284, ARG 286 and an additional GLY 161 with an unfavourable 
donor-donor bond. The Asp protein WP_096097608 and Cefotaxime 
docking analysis is in coincidence with the Galaxysite interpretation. 
The template 3VSL_B, structure of Penicillin-binding protein with 
methicillin resistance is identified by the GalaxySite analysis in the 
identification of ligand Cefotaxime concerning WP_096097608. 
Similar molecular docking analysis with binding energy-4.66 
kcal/mol involving Asp enzyme and Ciproflaxin is earlier reported 
by Vimal and team [51]. 
The protein WP_095730301 docked with Asparagine (fig. 6C) 
exhibited Conventional H bonds with only ASN 45 and THR 161 and 
van der Waals forces with ARG 42, SER 43, LYS 46, GLN 49, GLU 63, 
ALA 66, LEU 67, TYR 112, ALA 164, ALA165 residues. The 
Cefotaxime and WP_095730301 docked pattern (fig. 6D) is 
visualised to have salt bridges and π-π stacked bonds in addition to 
the bonds displayed by WP_096097608 however, no unfavorable 
bonds are observed. GLY 57, TYR 147 showed a carbon-hydrogen 
bond while ASP 59 appeared to be a Hydrogen bond with an oxygen 
atom. Multiple bonds are observed by HIS 72 with a π-π stacking and 
two H bonds anticipated for the overall stability of the Asp-
Cefotaxime protein. Similarly, ASP 149 also possesses multiple 
interactions with a carbon-hydrogen bond, salt bridge, π-anion and 
hydrogen bond. In addition, ILE 53, LEU residues 58, 65, 144 and 
148, ALA residues 68 and 69, SER 71 and 146, ASP 145 exhibited van 
der Waal bonds. 
  
 
Fig. 6: Molecular Docking studies: [A] WP_096097608 with Asparagine [B] WP_096097608 Cefotaxime [C] WP_095730301 with 
Asparagine [D] WP_095730301 with Cefotaxime. The upper half of each panel represents 3d surface images obtained from PyRx analysis 
while the lower part of each panel displays 2D interactions illustrated by the Discovery studio 
 
It is observed that the GalaxyTBM predicted Asp proteins structures 
on subjecting to docking studies, reported favourable results. 
Specifically, Asp-Asparagine docked conformation with-5.1 and-4.9 
kcal/mol is within the acceptable binding affinity interpretations by 
different researchers studied in different organisms such as in 
Salmonella typhimurium, Pectobacterium carotovorum, The Autodock Vina predictions concerning Asp protein 
WP_096097608 exhibiting an affinity of-6.8 kcal/mol towards 
Cefotaxime despite the presence of an unfavorable bond which is 
Streptomyces 
scabrisporus reported binding energy of-5.49,-5.51,-4.62 kcal/mol 
respectively concerning the docking analysis with Asparagine [51-
53]. Although much higher binding affinities are expressed in 
different sources of Asp enzyme, the current analysis focuses on new 
insights of Asp-Asparagine confirmation from two S. albidoflavus 
proteins.  
Ramesh et al. 
Int J App Pharm, Vol 13, Issue 4, 2021, 160-167 
 
166 
considered to impact the stability of the protein. On contrary, no 
such unfavourable bonds appeared with WP_095730301 docked 
structure exhibiting binding energy-6.5 kcal/mol is also considered 
to enhance the stability due to the hydrogen and stacked π bonds. 
CONCLUSION 
The present study on S. albidoflavus Asparaginase sequences 
identified the protein structures with stable 86.039, 89.161 ERRAT 
scores. The Asp protein WP_096097608 is found dominant with 
binding energy higher than WP_095730301 protein towards 
Asparagine. Thus the Asp homology and Asp-Asparagine docking 
analysis are considered as a successful step towards the quest for 
alternative Asp sources which may further be evaluated for molecular 
dynamic simulations and immunogenicity assessments. Similarly, the 
Asp-Cefotaxime interaction may be beneficial during anti-tumor drug 
development and also may be further analysed as an effective 
antibiotic to microbes that require Asp as a necessary enzyme.  
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